Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s stock price traded up 9.2% during trading on Monday . The stock traded as high as $353.79 and last traded at $346.33. 5,024,784 shares traded hands during trading, a decline of 9% from the average session volume of 5,542,213 shares. The stock had previously closed at $317.06.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the stock. Morgan Stanley boosted their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. TD Cowen boosted their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research note on Wednesday, May 6th. Barclays boosted their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $233.75.
Get Our Latest Analysis on Astera Labs
Astera Labs Stock Down 3.2%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current year.
Insider Activity
In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,321,256 shares of company stock valued at $480,893,146 over the last three months. Insiders own 10.40% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares during the period. Atreides Management LP lifted its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the period. State Street Corp lifted its position in Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the period. Geode Capital Management LLC lifted its position in Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the period. Finally, Fred Alger Management LLC lifted its position in Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares during the period. Institutional investors own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
